Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma - Business Wire
[unable to retrieve full-text content] Emerging biomarkers and frontier therapies: unveiling the role of endothelial dysfunction in cerebral small vessel disease Frontiers
[unable to retrieve full-text content] Progress on Cardiovascular Disease Care in the U.S. Has Stalled Despite Treatment Advances, New Report Finds The Harvard Crimson
Comments
Post a Comment